NC
IRWD icon

NewSquare Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

NewSquare Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-595
Closed -$6.81K – 492
2023
Q4 		$6.81K Hold
595
– – ﹤0.01% 303
2023
Q3 		$5.73K Hold
595
– – ﹤0.01% 370
2023
Q2 		$6.33K Hold
595
– – ﹤0.01% 396
2023
Q1 		$6.26K Hold
595
– – ﹤0.01% 416
2022
Q4 		$7.37K Hold
595
– – ﹤0.01% 325
2022
Q3 		$6K Hold
595
– – ﹤0.01% 289
2022
Q2 		$7K Hold
595
– – ﹤0.01% 263
2022
Q1 		$7K Hold
595
– – ﹤0.01% 281
2021
Q4 		$7K Hold
595
– – ﹤0.01% 302
2021
Q3 		$8K Hold
595
– – ﹤0.01% 286
2021
Q2 		$8K Buy
+595
New +$6.81K ﹤0.01% 276

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

NewSquare Capital's IRWD Position: Q1 2024 in Review

NewSquare Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2024, closing a stake of 595 shares — an estimated $6.81K sold.

NewSquare Capital first reported a position in IRWD in Q2 2021 and held it in 11 quarters. The position peaked at $8K in Q3 2021. 261 funds tracked by Wall St. Rank hold IRWD as of Q1 2024.

  • NewSquare Capital reported no remaining Ironwood Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • NewSquare Capital sold 595 Ironwood Pharmaceuticals shares in Q1 2024, an estimated $6.81K.
  • NewSquare Capital first reported a position in Ironwood Pharmaceuticals in Q2 2021 and held it in 11 quarters.
  • NewSquare Capital's Ironwood Pharmaceuticals position peaked at $8K in Q3 2021.
  • 261 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2024.

Based on NewSquare Capital's 13F filing for Q1 2024, filed 8 May 2024.